This approval may offer greater flexibility for healthcare providers and people living with multiple sclerosis, based on their individual treatment needs, Roche CMO Levi Garraway said in a statement
However, if semaglutide presents a measurable risk for NAIONespecially when alternative GLP-1s might notthe stakes change for those already vulnerable (e.g., with ocular or cardiovascular risk factors) to this serious eye condition, often described as eye stroke. What Should Patients Do
Colonic potassium handling
Some people think that supplementing with the building blocks of glutathione, like N-acetyl-cysteine (NAC), helps to make glutathione, but this isnt always true
GLP-1R downregulation can diminish the effects of GLP-1 and its analogues on target cells
West S, Aveyard P, Scragg J, et al